CJC-1295 (without DAC) and Thymosin Beta-4 Interaction

Synergistic
Mechanism-based 47% confidence

CJC-1295 (without DAC) and Thymosin Beta-4 have a synergistic interaction with 47% confidence. CJC-1295 (without DAC) and Thymosin Beta-4 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Thymosin Beta-4

43-Amino Acid Regenerative Peptide | Tissue Repair & Healing

Direct systemic delivery provides optimal bioavailability and distribution to target tissues for comprehensive regenerative effects including angiogenesis, cell migration, and differentiation..

Half-life: Dose-dependent; relatively short (exact values not established) Typical dose: 2-6mg per injection (varies by protocol and severity) healing, immune, longevity
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Blood Vessels
low

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with Thymosin Beta-4?

Yes, CJC-1295 (without DAC) and Thymosin Beta-4 can generally be taken together. CJC-1295 (without DAC) and Thymosin Beta-4 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is CJC-1295 (without DAC) and Thymosin Beta-4 safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between CJC-1295 (without DAC) and Thymosin Beta-4?

CJC-1295 (without DAC) and Thymosin Beta-4 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and Thymosin Beta-4?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Thymosin Beta-4 has a half-life of Dose-dependent; relatively short (exact values not established). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs Thymosin Beta-4

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.